Anthropic valuation hitting $3.0T by December 31 priced at 20.5% on Polymarket

Anthropic’s chances of reaching a $3.0T valuation by December 31 were priced at 20.5% on Polymarket in the supplied Oct 16, 2026 update, published at 7:54 AM ET. The YES contract stood at 20.5c, down 1.0c over 24 hours, with $79.6K traded.

A valuation milestone loses ground

The contract concerns a fundraising and business outcome rather than a publicly traded share price. Its pricing puts the $3.0T threshold below an even chance, while the daily decline indicates a modest retreat in market expectations.

According to PolymarketTrader, the Anthropic contract appeared at position 16 in its biggest-movers list. The site’s snapshot was generated from the Polymarket Gamma API at 2026-10-16 01:48 UTC, making it a dated observation rather than a live quote.

No catalyst identified

The supplied material does not identify a fundraising announcement or other company development behind the decline. It also does not provide the Anthropic contract’s resolution criteria, spread or available liquidity, limiting what can be concluded about the repricing.

PolymarketTrader describes its list as a filtered research screen. Its methodology excludes rows with less than $1,000 in 24-hour volume and treats changes smaller than 0.2¢ as noise. The outlet cautions that price movements can reflect new information, limited liquidity or proximity to resolution; inclusion alone does not establish the cause of a move.

What it means for prediction markets

• The threshold matters: The 20.5% price applies to Anthropic reaching $3.0T by December 31, not to a broader judgment about the company’s prospects.
• Direction is clearer than explanation: The contract fell 1.0c in 24 hours, but the supplied reporting establishes no catalyst.
• Volume is not the full liquidity picture: The reported $79.6K traded does not establish the spread or depth available in the order book.
• Settlement details remain a gap: Without the resolution criteria, the material does not establish what evidence would qualify as reaching the valuation target.